Xenoreactive antibodies and latent fibrin formation in VAD and cardiac transplant recipients can confound the detection and measurement of anti-AT1R antibodies-Reference-Cited by-同舟云学术

Xenoreactive antibodies and latent fibrin formation in VAD and cardiac transplant recipients can confound the detection and measurement of anti-AT1R antibodies

Published:2018-04-24 Issue:11 Volume:18 Page:2763-2771
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Oaks Martin¹,Michel Karen¹,Downey Francis X.²,Thohan Vinay²

Affiliation:

1. Transplant Research Lab; Aurora St. Luke's Medical Center; Milwaukee WI USA

2. Aurora Cardiovascular Services; Aurora St. Luke's Medical Center; Milwaukee WI USA

Funder

Department of Cardiovascular Surgery

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14753/fullpdf

Reference49 articles.

1. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies;Gupta;Transplantation,2014

2. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the standardization of nomenclature in the pathologic diagnosis of antibody-mediated rejection in heart transplantation;Berry;J Heart Lung Transplant,2013

3. Morphologic and immunohistochemical findings in antibody-mediated rejection of the cardiac allograft;Fishbein;Hum Immunol,2012

4. 2013 annual literature review of donor-specific HLA antibodies after organ transplantation;Kaneku;Clin Transpl,2013

5. Incidence and impact of de novo donor-specific alloantibody in primary renal allografts;Everly;Transplantation,2013

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical conundrums in pediatric kidney transplantation: What we know about the role of angiotensin II type I receptor antibodies in pediatric kidney transplantation and the path forward;Pediatric Transplantation;2024-04-23

2. Allorecognition and the spectrum of kidney transplant rejection;Kidney International;2021-12

3. CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients;Journal of the American Society of Nephrology;2021-11-30

4. The effect of pre-transplant and post-transplant anti-AT1R antibodies in heart transplant recipients;Transplantation Reports;2020-12

5. A Comprehensive Overview of the Clinical Relevance and Treatment Options for Antibody-mediated Rejection Associated With Non-HLA Antibodies;Transplantation;2020-11-17